Health Care · Pharmaceutical Preparations · Nasdaq · CIK 2081043 · FYE Dec 31 · Prices AT CLOSE 2026-08-21 (USD) Last $7.38 · Day −0.54% · Mkt cap $2.7B · 1Y +68.1% · Off 52W high −0.9% · Vol (1Y) 80.3% Price2023-08-21 → 2026-08-21 ATAI close: $1.63 on 2023-08-21 to $7.38 on 2026-08-21. Split-adj closes · 240 of 1,296 · price returnⓘ At a glance | Short interest5.4% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)−0.05% | | Top-10 13F concentration64.1% | | Next report (est.)2026-10-29 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$4.1M | | Earnings (TTM)-$660.0M | | ROE−390.4% | | Net margin−16142.0% | | ROIC−397.1% | | Debt / equity0.00× |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+80.4% | | 1Y+68.1% | | 3Y+352.8% | | 5Y−54.0% | | Since incept. (ann.)−16.6% |
Total return · from 2021-06-22ⓘ Risk | Ann. volatility (1Y)80.3% | | Ann. volatility (3Y)88.3% | | Sharpe (1Y)1.16 | | Sharpe (3Y)1.00 | | Max drawdown (1Y)−48.1% | | Max drawdown (3Y)−59.2% | | Beta (3Y vs SPY)2.10 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Deep Track Capital, LP | 12.0M | $42M | 3.29% | new | | VANGUARD CAPITAL MANAGEMENT LLC | 11.8M | $42M | 3.22% | new | | UBS Group AG | 7.4M | $26M | 2.04% | new | | BlackRock, Inc. | 6.8M | $24M | 1.87% | new | | ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.6M | $20M | 1.55% | new | | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 5.3M | $19M | 1.45% | new | | MILLENNIUM MANAGEMENT LLC | 4.4M | $15M | 1.20% | new | | MORGAN STANLEY | 3.9M | $14M | 1.06% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-11 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-11 | −$0.09 | — | $1.7M | +137.0% | | 2026-03-31 | 2026-05-12 | −$0.08 | — | $954,000 | −38.6% | | 2025-06-30 | — | −$0.14 | — | $719,000 | — | | 2025-03-31 | — | −$0.15 | — | $1.6M | — |
As-reported XBRL · next 2026-10-29 est.ⓘ Segment mixFY2025 (ended Dec 2025) Research And Development Services Revenue 95% · License 5% product & service · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
